In LaDonna Bonnin’s line of work, the details really matter. As associate director of the New Mexico Poison and Drug ...

As a youth activist in Colorado, I’ve spent years organizing around the issues that shape our generation’s lives — and across ...

By Andrew Silver SHANGHAI, Jan 30 (Reuters) - AstraZeneca will license experimental drugs for obesity and weight-related ...

Last year, there was a 15% annual increase in the operations and surgeons want more research.

Symptoms to look out for include severe pain in the stomach and back which does not go away.

Pfizer reported strong mid-stage weight loss trial results for its monthly obesity drug and posted fourth-quarter earnings ...

More than 1 in 8 American adults are using GLP-1’s for weight loss. Experts say these are the nutritional gaps and side effects that should not to be overlooked.

Nutritionist Rujuta Diwekar reveals the truth about the protein trend and whether it is truly the magic bullet we have been ...

Medicines and Healthcare products Regulatory Agency experts have issued a stern warning over two particular brands ...

Pfizer highlighted another fall in quarterly revenues tied to Covid-19 products, and $4.4 billion in asset impairments ...

Eating more protein is in vogue, thanks to popular diets, the power of social media influencers and the advent of GLP-1 ...

The disruptive force of weight loss drugs: How GLP-1s do more than shed pounds - The impacts of weight-loss medications reach ...